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Biochem istry

Quantification o f Feline Immunodeficiency Virus (FIVpco) in peripheral blood
m ononuclear cells, lym ph nodes and plasm a o f naturally infected cougars

Chair: Stephen Lodmell
Infection o f domestic cats widi Feline Immunodeficiency Virus (FIV) results in a fatal
im m unodeficiency disease, similar to human immunodeficiency virus ty p e-1 (HIV-1) in
humans. Elevated plasm a viral loads in domestic cats are correlated to decreased survival
tim e and disease progression. FIV is also maintained as an apathogenic infection in other
m em bers o f the family Felidae including cougars. Puma concolor (FIVpco). It is not
know n w hether the lack o f disease in cougars is a result o f diminished viral replication. A
real-tim e PC R assay was developed to quantify both FIVpco pro viral and plasm a viral
loads in naturally infected cougars. Pro viral loads quantified from peripheral blood
m ononuclear cells (PBM C) ranged from 2.90x10^ to 6.72x10"^ copies per 10^ cells.
Plasm a viral loads ranged from 2.30x10^ to 2.81x10^ RNA copies per ml. These data
indicate that FIVpco viral loads are comparable to viral loads observed in endemic primate
lentivirus infections. Thus the lack o f disease in cougars is not due to low levels o f viral
replication. M oreover, significant differences observed among cougar PBM C proviral
loads correlated to viral lineage and cougar age (P = 0.014), which suggests that sepairate
life strategies exist within FIVpco lineages. This is the first study to demonstrate that an
interaction o f lentiviral lineage and host age significantly affects proviral loads.
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Chapter 1
Introduction

Introduction to lentiviral infections and disease
Lenti viruses are RNA viruses associated with the family Retroviridae. These
viruses replicate their genomes through a reverse transcriptase enzyme and are frequently
characterized by an extended incubation period prior to any evident signs o f disease. For
example, hum an imm unodeficiency virus type-1 (HIV-1) infection in humans begins
with an acute infection and over a period o f years, progresses to immunodeficiency and
ultimately death. W hile m uch attention has been paid to HIV-1 because o f its enormous
public health threat (Armstrong et al., 2005), lentiviruses infect a num ber o f other
animals such as sheep (visna virus), horses (equine infectious anemia virus), non-human
primates (simian im m unodeficiency virus (SIV)) and felines (feline immunodeficiency
virus (FIV)) (Ligne, 1843, Lowenstine et al., 1986, Sigurdsson et al., 1952). Although
many lentivirus infections are associated with disease, such as HIV-1 in humans and FIV
in domestic cats, some lentivirus infections are endemic within wild populations and do
not result in disease. For example, endemic lentivirus infections in A frican green
monkeys (SIVagm), sooty mangabeys (SIVsm) and cougars (FIVpco) results in no
observable disease despite elevated viral loads (Holzam m er et al., 2001, Olmsted et al.,
1992, Rey-Cuille et al., 1998). Therefore, all lentivirus infections are not associated with
pathogenic diseases.

Genomic organization o f FIV

Feline imm unodeficiency virus (F IV ) is a lentivirus that infects members o f the
family Felidae worldwide. Although all FIV strains detected in w ild and domestic cats
form a m onophyletic cluster in a phylogeny o f lentiviruses, each feline species is infected
w ith a distinct virus and infection results in disparate outcomes (Burkhard & Dean, 2003).
FIV is m aintained as an apathogenic infection in some members o f the cat family such as

lions {Panthera led) and cougars {Puma concolor) (FIVpco) (Brown et al., 1994,
Carpenter & O'Brien, 1995, Olmsted et al., 1992). However, FIV infection in domestic
cats results in a disease sim ilar to HIV-1 in humans (Bendinelli et al., 1995, Pedersen et
al., 1987).
The genome o f FIV encodes three genes that are com m on to all retroviruses; gag,
p o l and env. Gag and env encode structural proteins that are necessary for virion
assembly while p o l encodes the enzymes needed for viral replication (Burkhard & Dean,
2003, Inoshima et al., 1998). Since FIV is a lentivirus, it also contains additional
accessory genes that encode nonstructural proteins that alter viral gene expression and
pathogenesis. One o f these accessory genes, rev, is conserved across all lentiviruses and
provides an essential m echanism by w hich partially and unspliced viral RNAs are
exported from the nucleus (M iller et al., 2000). A transactivating gene is also encoded by
all lentiviruses and plays an important role in viral transcription. The transactivating
protein in FIV, Orf2, also facilitates transactivation but through a unique mechanism
com pared to transactivating proteins from other lentiviruses (Chatterji et al., 2002). Kz/'is
also encoded by all lentiviruses except equine anem ia virus and is necessary in HIV-1
infections to suppress a host-derived antiviral factor, APOBEC3G (Rose et al., 2004).
FIV is genetically distinct from primate lentiviruses because it encodes a dUTPase gene

(M iller et al., 2000). dUTPase hydrolyzes dUTP into dUM P to m aintain a low
concentration o f dUTP in the cell in order to reduce the opportunity o f uracil
m isincorporation during reverse transcription. Finally, FIV does not encode accessory
proteins such as vpr^ vpu or n e f as primate lentiviruses do.

Retroviral Life Cycle
Although FIV is phylogenetically distinct from other lentiviruses, the viral life
cycles o f all lentiviruses are similar and can be divided into six distinct steps that include
entry, uncoating, integration, transcription, assem bly and budding (Fig. 1.1). FIV utilizes
CD 134 as a prim ary receptor as well as the chemokine coreceptor, CXCR4 for
attachment and entry (de Parseval et al., 2004a, de Parseval et al., 2004b, Shimojima et
al., 2004). A fter attachment and membrane fusion the viral core, which includes the fulllength genomic RNA and the viral reverse transcriptase (RT), is deposited into the
cytoplasm. The viral genomic RNA is reverse transcribed by RT to form a full-length
double stranded DNA copy. The double-stranded DNA then forms a preintegration
com plex with viral integrase (IN) and translocates to the nucleus. Integration o f the viral
DNA is catalyzed by IN and results in the random insertion o f the viral DNA into the
host genome. The integrated viral DNA form is called the pro virus. After integration,
transcription o f the pro virus by the host cell RNA polymerase II produces both full length
genomic RN A as well as singly and fully spliced viral transcripts. These transcripts are
subsequently translated into viral proteins such as Gag and Gag-Pol precursors, which are
assem bled into imm ature viral particles along with the full length genomic RNA. The
assem bled imm ature virions then bud from the host cell membrane. M ature virions are

produced after the viral protease (PR) cleaves the Gag and Gag-Pol precursors to form
infectious viruses. Hence, lentiviruses exist as an integrated DNA provirus within an
infected cell and as a cell free RNA virus circulating in the blood.
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Figure 1.1 : A schematic o f the retroviral life cycle. Lentiviruses exist in both an RNA and
DNA form during infection. Lentiviruses are present as infectious cell free virions, which
contain the full length viral genomic RNA (indicated in red). A fter attachment and entry,
the genomic RNA is reverse transcribed to double-stranded DNA (indicated in green) and
integrated into the host cell genome (indicated in black), w hich is called the provirus.

Importance o f viral loads on disease progression
Viral expression levels provide im portant inform ation on the state o f pathogenic
lentivirus infections. In both HIV-1 and FIV infections, the acute stages o f infection are
associated w ith high plasm a viral loads (Diehl et al., 1995, Piatak et al., 1993a, Piatak et
al., 1993b). As the infection persists, viral RNA levels decrease and usually remain
detectable throughout the infection. Viral RNA levels increase again in the terminal stage
o f the infection (Diehl et al., 1995, Gupta et al., 1993). Although viral expression levels
increase during the beginning and end o f pathogenic lentivirus infections, the am ount o f

cell free virus during the asymptomatic stage o f the infection is the m ost robust
prognostic indicator for disease progression and has been shown to correlate to survival
tim es in FIV and HIV-1 (Diehl et al., 1996, Goto et al., 2002, M ellors et al., 1996).
Plasm a viral loads have been shown to correlate to disease stage in both
experimental and natural FIV infections in domestic cats. Domestic cats experimentally
infected with FIV that progress rapidly to disease m aintain plasm a viral loads 1 to 2 logs
higher than long-term survivors (Diehl et al., 1996). M oreover, the total amount o f antiFIV antibodies is not different between rapid disease progressors and long-term survivors
indicating that FIV replication plays an im portant part in FIV disease progression. The
premise that plasm a viral loads are correlated to disease in FIV infections is also
supported by observations from naturally infected domestic cats. High plasma viral loads
(> 10^ RNA copies per ml) in naturally infected domestic cats correlate to progression to
feline AIDS as well as decreased survival tim es (Goto et al., 2002). Therefore, the
amount o f virus circulating in the blood o f infected domestic cats provides a strong
clinical m arker for disease outcome and survival tim e during FIV infections.
Since elevated plasm a viral loads are also correlated to disease progression in
patients infected w ith HIV-1 (M ellors et al., 1996), patients currently receive highly
active retroviral therapy (HAART), w hich enables them to remain free from clinical
symptoms. HA ART includes a combination o f nucleoside and nonnucleoside inhibitors
o f the reverse transcriptase and protease enzymes that substantially inhibit the level o f
viral replication and decrease plasm a viral loads to undetectable levels (Kulkosky &
Pomerantz, 2002). Once plasm a viral loads decrease to undetectable levels in patients
(<50 copies per ml o f blood), proviral loads become an im portant measure o f efficacy o f

antiretroviral therapy. The proviral reservoir is the m ajor obstacle in the complete
eradication o f the virus. HAART therapy has been shown to also decrease HIV-1 proviral
loads, how ever the rate at which HIV-1 proviral loads decrease are m uch lower than that
o f plasm a viral loads (Dickover et al., 1992). Therefore, after prolonged HAART therapy,
proviral loads provide a second clinical m arker by which to compare the efficacies o f
different antiretroviral therapies (Desire et al., 2001, D ickover et al., 1992).

Viral loads in endemic apathogenic SIV infections
In contrast to pathogenic lentivirus infections in domestic cats and humans,
primates infected w ith SIV m aintain substantial viral loads but do not progress to disease.
The amount o f cell associated and cell free virus in infected African green monkeys
(AGM) and sooty mangabeys (SM) indicates that these infected prim ates maintain viral
loads equivalent or higher than viral loads in pathogenic lentivirus infections in domestic
cats or humans despite rem aining free from disease. For example, proviral loads
quantified in three naturally infected sooty m angabey ranged from 2450 to 6020 DNA
copies per 10^ PBMCs, with a mean o f 4.6x10^. Plasm a viral loads quantified from these
SM ranged from 4.7x10^ to 1.2x10^ RNA copies per m l (Rey-Cuille et al., 1998). In
African green m onkeys proviral loads were lower than in SM and ranged from 33 to 333
DNA copies per 10^ PBM Cs and 333 to 3333 DNA copies per 10^ LN cells. However,
plasm a viral loads quantified from AGM in a separate study were similar in magnitude to
SM (range 3.5x10^ to >9.5 xlO^ copies/ml) (Broussard et al., 2001). One study quantified
plasm a viral loads in six AGM ranging from less than 10^ RNA copies per ml to 8x10^
(Goldstein et al., 2000). In a m uch larger study, viral loads in AGM ranged from 8.3x10^

to 1.1x10^, w ith a m ean o f 1.7x10^ RNA copies per ml (Holzam m er et al., 2001). These
data clearly indicate that naturally infected SM and AGM m aintain a productive lentiviral
infection despite rem aining free from disease. Therefore, the am ount o f virus in an
infected individual or animal is not always predictive o f disease.

Quantification o f viral loads
Since viral loads are frequently an informative measure o f disease progression,
several methods have been designed to quantify the am ount o f virus in an infected animal
or patient. Com petitive PCR is one m ethod used to measure viral loads (Clementi et al.,
1994, Orlando et al., 1998). In com petitive PCR both the target and a truncated
competitor are am plified sim ultaneously w ith the identical forward and reverse primer set.
To insure that quantification through competitive PCR is accurate, the amplification
efficiencies o f both the target and com petitor m ust be equal. W hen both templates
amplify uniformly, the ratio o f template and com petitor will rem ain constant throughout
the PCR. Therefore, to quantify the initial am ount o f target, an equal ratio o f target to
com petitor m ust be identified through am plification and subsequent densitometry
analysis. The initial amount o f target is then calculated by determining the starting
quantity o f com petitor used in that particular reaction.
Com petitive PCR is labor intensive and necessitates m uch post-PCR analysis.
Even before quantification begins, a DNA or RNA com petitor m ust be created for every
target o f interest and that com petitor must am plify with equal efficiency. Several
dilutions m ust be tested to achieve a suitable ratio. Furthermore, the post-PCR
quantification m ust be thorough and accurate to provide a correct estim ation o f the initial

target amount. A fter all these controls are completed, the initial am ount o f target can only
be calculated to w ithin a ten-fold difference o f the competitor.
Com petitive PCR has been previously used to measure feline proviral loads from
several different tissues in domestic cats (Pistello et al., 1994). The number o f FIV copies
per m icrogram o f genom ic DNA was quantified by utilizing a fixed am ount o f cellular
DNA and a know n am ount o f com petitor DNA w ith a 21 base pair deletion,. Interestingly,
a dynamic range o f proviral loads were quantified, ranging from 4300 copies in CNS
tissue to as low as 10 copies per 10^ cells in ovary tissue. However, since the target
amplicon was larger the results m ay be skewed due to an increased am ount o f ethidium
bromide being incorporated into the target am plicon compared to the competitor, which
would produce inaccurate results (Pistello et al., 1994). A second group worked to
eliminate this quantification problem by utilizing a fluorescent labeled second round PCR
prim er to create a m ore specifically labeled PCR product (Cammarota et al., 1996).
However, a separate enzyme digestion was necessary after amplification, which created
another possible vairiable in the quantification. Competitive PCR is labor intensive and
does not always lead to repeatable, accurate results. Consequently, a more sensitive and
accurate method o f quantification has been developed.
Real-time PCR is a quantitative fluorescent-based PCR method that monitors the
level o f fluorescence during every cycle o f a PCR reaction (i.e. in real-time) (Niesters,
2002). The fluorescent signal is proportionate to the amount o f PCR product in the
reaction and increases every cycle. Real-time PCR accurately quantifies the initial
am ount o f target tem plate by comparing the level o f fluorescence o f an unknown sample
to the fluorescence o f a known copy number standard. Q uantification through real-time
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PCR is quicker than competitive PCR methods because real-tim e PCR eliminates any
post-PC R processing steps. More importantly real-time PCR is able to detect a number o f
target tem plates over a broad dynamic range thereby making quantification more accurate
(Niesters, 2001).
A variety o f different chemistries are currently available for real-time PCR assays.
For example, Taqm an chemistry utilizes a fluorogenic probe during PCR amplification
that specifically hybridizes to the teirget sequence. Taqman probes are oligonucleotides
slightly longer than the primers that contain a fluorescent reporter on the 5’ end along
with a quencher at the 3 ’ end. W hen the probe is not bound to the target sequence and
then irradiated during am plification, the fluorescent dye excites and its energy is
transferred to the quencher producing no fluorescent signal. However, when the probe
hybridizes to the target sequence, the reporter is cleaved by the 5’ exonuclease activity o f
the Taq polymerase during the extension step o f the PCR reaction. Cleavage and
subsequent irradiation results in an increase in fluorescence. Since the probe only
hybridizes with the target sequence, it is specific. Moreover, Taqman chemistry is able to
detect down to a single copy o f the target sequence in a given reaction. Therefore,
because o f its specificity and sensitivity, Taqman chemistry is the most popular real-time
chemistry em ployed to date.
A less expensive alternative to Taqman chemistry is using real-time PCR with an
intercalating DNA dye such as SYBR green. SYBR green dye is similar to ethidium
brom ide and fluoresces only when bound to double-stranded DNA. Although SYBR
green is a cheaper option, a m ajor difficulty with this chemistry is that the dye fluoresces
when bound to any double-stranded DNA products, including non-specific products.

Consequently to accurately quantify copy num ber w ith SYBR green, it is essential to
optim ize the reactions and amplify only the target o f interest. Although intercalating dyes
are less specific, a quality control measure is available for this chemistry that is not
available w hen using Taqman probes. A post-PCR m elt curve analysis is a useful method
to ensure a single PCR product is amplified w ith SYBR green. After amplification is
complete, the tem perature o f the thermal cycler increases incrementally over time. As the
temperature increases any double stranded DNA denatures, releasing the fluorophores,
and thereby producing a spike o f fluorescence. If only one PCR product accumulates then
only a single peak will be observed in the m elt curve analysis. However, if shorter PCR
products are amplified such as primer-dimers two or more peaks will be visualized.
During real-time am plification the threshold cycle num ber (Ct) is the principal
measure o f fluorescence. The Ct is the cycle num ber at w hich a significant increase in
fluorescence is first detected. The threshold cycle num ber is correlated to the exponential
growth phase o f PCR amplification. The Ct value is determined after a real-time PCR
amplification and usually represents 10 times the fluorescent variance w ithin the assay.
The higher the initial am ount o f target w ithin a reaction, the sooner the accumulated
product will be detected producing a lower Ct value. Therefore, by amplifying a series o f
DNA standards o f known copy number and plotting copy number versus Ct values, a
linear standard curve is produced (Fig. 1.2). This curve can then be used to quantify
unknowns w ithin the same run.
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Figure 1.2: Quantification through real-time PCR. A series o f m yosin standards with a
known number o f copies were amplified through real-time PCR indicated by the blue
circles. The numbers o f standard copies (log quantity) are plotted against their respective
threshold cycle values (Ct). The linear curve generated can then be used to estimate the
initial copy num ber o f unknowns that were amplified in parallel indicated by red squares.

Since real-time PCR enables a quick and reliable m ethod by which to quantify the
number o f target copies in an unknown sample, we developed two novel real-time PCR
assays to determine both the proviral and plasm a viral loads in infected cougars using
both Taqman and SYBR green chemistries. Although real-time PCR is a sensitive
m ethod o f detection, the extensive divergence o f FIVpco m ay be a problem in accurately
quantifying the amount o f virus in infected cougars. The viral diversity observed in
cougars is know n to be larger than the diversity observed in domestic cats (Carpenter et
al., 1996). N ucleotide mismatches within the prim er binding site have been shown to
result in disparate am plification efficiencies between standards and unknowns (Klein et
al., 1999). M oreover, a difference in amplification efficiencies between standards and
unknowns can dram atically affect quantification (Leutenegger et al., 1999). Therefore,
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the real-tim e PCR protocol was optimized to ensure proper am plification and accurate
quantification.
Because F IV is maintained as an endemic apathogenic infection in cougars, Puma
concolor (FIVpco), we hypothesized that the lack o f disease in cougars may be a result o f
diminished viral replication. To test this hypothesis, a real-time PCR assay was
developed to quantify FIVpco proviral and plasm a viral loads from infected cougars. The
Specific Aim s that were addressed in the research presented here:

Specific Aim 1: To develop a real-tim e PCR assay to quantify FIVpco proviral and
plasma viral loads.
Specific Aim 2: To quantify proviral and plasma viral loads from peripheral blood
m ononuclear cells (PBM C), lymph nodes (LN) and plasma o f infected cougars

12

Chapter 2
Establishm ent o f the FIVpco proviral and plasm a viral load real-time PCR assay

In order to develop a real-time PCR assay that accurately quantifies FIVpco
proviral loads in infected cougars, three m ain objectives m ust be accomplished. First,
real-time prim ers m ust be designed to quantify both the num ber o f cell equivalents and
the num ber o f FIVpco pro vial copies. Then the optimal prim er concentrations for each
primer set must be established experimentally. Finally, the real-time assay must be
designed so that the plasm id DNA standards and the genomic unknowns amplify with
equivalent efficiencies. A fter these three objectives are com pleted proviral loads can be
accurately quantified from cougar PBM C and LN samples.

Prim er Design
Primer design for quantitative RT-PCR is typically accomplished through a
com puter program from Applied Bioscience Inc. (ABI) called Prim er Express. This
program accounts for certain variables that inhibit efficient real-time amplification by
selecting prim ers and probes according to the following set o f criteria. First, both the
forward and reverse prim er are designed to have a Tm, which is defined as the
temperature at w hich 50 percent o f the prim er concentration is bound to the target
sequence, o f approxim ately 58 to 60°C. Additionally, the G-C content for each primer is
designed to be between 20 and 80 percent and each prim er does not have more than 40
percent o f G ’s or C ’s at the 3’ end. Finally, the size o f the real-time PCR amplicon is
lim ited to between 50 and 150 basepairs (bp) because smaller amplicons give more

13

consistent results and are more efficiently am plified in real-time. W hile designing the
probe tw o m ajor criteria are addressed. First, the 5 ’ end o f the probe must not include a
guanine because this nucleoside base acts as a natural quencher during amplification.
Second the num ber o f G ’s cannot be greater than the num ber o f C ’s.
Proviral loads are typically calculated based upon the num ber o f viral DNA
copies per m illion cell equivalents (Damond et al., 2001, Desire et al., 2001). Therefore,
to quantify FIVpco proviral loads from infected cougar PBM C and LN, the number o f cell
equivalents and the num ber o f FIVpco proviral copies must be determined for each
genomic sample. In this assay a portion o f exon 19 o f the cougar myosin gene was
selected as our determ inant for the num ber o f cell equivalents. Since this gene is well
conserved in cougars, a Taqman prim er and probe set was created that was 100%
complementary to the m yosin sequence. However, to quantify FIVpco copy number, no
suitable Taqman probe could be designed because o f the extensive sequence divergence
within FIVpco Previous FIVpco phylogenetic studies have established that distinct viral
lineages o f FIVpco exist w ithin cougar populations in western N orth A merica and that the
genetic diversity among cougar lentiviral lineages is greater than the diversity observed in
FIV in domestic cats (Biek et al., 2003, Carpenter et al., 1996). Therefore, SYBR green

chemistry was used for the quantification o f FIVpco- The FIVpco primer set targeted a
conserved region located at the 3 ’ end o f the putative env gene, which amplified a 170 bp
fragment.

Construction o f plasm id DNA standards
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After the m yosin and FIVpco prim er sets were identified through Primer Express,
DNA plasm id standards were created for both m yosin and FIVpco. In the case o f myosin,
genom ic cougar D NA was PCR amplified using the real-tim e m yosin primers. For the
FIVpco DNA standards, cougar genomic DNA was am plified from five separate cougars
that represented all FIVpco viral lineages. The PCR products for both myosin and FIVpco
were subject to gel electrophoresis, gel purified, ligated into the pDrive vector and cloned
(see Materials and M ethods, Chapter 3). Plasm id DNA was purified and quantified
through U V spectroscopy. To determine the num ber o f copies for each DNA standard the
following equations were used:
1) (bp size o f double-stranded product)(3 30 daltons x 2 nt/bp) = X daltons,
(daltons = grams/mole)
2) (X grams/mole) / (6.023 x 10^^ m olecules/m ole) = X grams/molecule
3) Plasm id concentration (g/pl) / X grams/molecule = # o f molecules o f
plasm id/pl

Rationale behind prim er concentration optimization
Real-time PCR prim er concentrations usually range from 50 to 900 nM. Therefore
the optimal prim er concentrations can be easily determined by independently varying the
forward and reverse prim er concentrations w ith a prim er matrix as seen in Table 2.1. The
primer concentrations that provide the optim al am plification are concentrations that yield
the lowest threshold cycle number (Ct) and that produce no prim er dimers. Primer dimer
formation is unwanted in real-time PCR reactions because they are non-specific products
and produce inaccurate results during quantification. Prim er dimer formation can
frequently be overcom e by using unequal forward and reverse prim er concentrations in
the PCR reaction.
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During any real-time prim er optim ization it is recom m ended that all
am plifications £ire done with SYBR green because o f two factors. First, SYBR green is a
more econom ical choice during optim ization than the Taqm an probe. Second, with
SYBR green a post-PCR m elt curve analysis can be done for all reactions to determine
whether any prim er dim er formation has occurred. N on-specific products are o f major
concern while using SYBR green chemistry because any nonspecific double stranded
DNA products bind the intercalating dye and fluoresce during the PCR reaction.
However, with Taqm an chem istry the probe is created to specifically hybridize to the
target sequence and therefore nonspecific products are not amplified. After the optimal
primer concentrations have been established, the am ount o f Taqman probe used for each
reaction can be optimized. Probe concentrations usually range from 50 to 250 nM per
reaction. A gain the optimal probe concentration is the concentration that results in the
lowest Ct value.

O ptim ization o f the myosin primers and probe
For the myosin prim er optim ization, a prim er matrix (Table 2.1) was prepared and
am plified with SYBR green w ith a single myosin standard at a concentration o f 8x 10^
copies per reaction. All reactions am plified (Fig. 2.1) and only a single peak was
observed in the m elt curve analysis (data not shown). The reactions that included the
highest forward and/or reverse prim er concentrations (900nM ) produced the lowest Ct
values, indicating that higher primer concentrations increased the robustness o f the real
tim e reactions. However, in a separate am plification reaction, using four different myosin
prim er concentrations and cougar genomic DNA (1.0 ug) as a template, the primer
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concentrations o f 300nM forward and lOOnM reverse produced the lowest Ct value (Fig.
2.2). All standards and genomic samples were run in duplicate and the average Ct values
from the duplicate reactions were calculated to determine the threshold cycle number.
Since the cougar m yosin gene was to be quantified from genomic cougar DNA, it was
sensible to choose the prim er concentrations (300F/100R) that am plified the genomic
cougar DNA m ore efficiently.
To determine the optimal m yosin probe concentration, two separate plasmid DNA
standards (8x10^ and 8x10^ copies per reaction) were am plified with the optimal myosin
primer concentration (300F/100R) along w ith three different concentrations o f the
myosin probe (50, 100, and 250nM per reaction). The Ct values obtained among all three
probe concentrations for each plasm id DNA standard were not significantly different
(data not shown). Therefore, the probe concentration was chosen to be 50nM per reaction.

Table 2.1: Prim er O ptim ization M atrix
Forward Primer (nM)
Reverse Primer (nM)
100
300
900

100
1 0 0 /1 0 0
3 0 0 / 100
9 0 0 / 100

300
1 0 0 /3 0 0
300 / 300
900 / 300
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900
1 0 0 /9 0 0
300 / 900
900 / 900
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Figure 2.1: O ptim ization o f the myosin prim er concentrations. A single myosin DNA
plasmid standard (8x10^ copies/reaction) was am plified through real-tim e PCR with
different concentrations o f both forward and reverse m yosin prim er indicated in the
legend.

M yosin Primer O ptim ization R e su lts

s
1
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n 900F/300R
m 100F/900R
□ 900F/100R
□ 300F/100R

o
o'

8 26.5

P rim er C o n c e n tr a tio n s

Figure 2.2: Optim ization o f the myosin prim er concentrations using cougar genomic
DNA. 1 ug o f cougar genomic DNA was amplified through real-time PCR with four
m yosin prim er concentrations indicated in the legend. The four myosin primer
concentrations am plified the myosin plasmid DNA standards with different efficiencies.

O ptim ization results o f FIVpco primer set
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To determine the optimal primer concentrations for the FIVpco primers, an
identical prim er matrix was amplified with a single FIVpco standard o f 4x10* FIVpco
copies per reaction utilizing SYBR green chemistry (Fig. 2.3). All reactions amplified
and produced a single peak in the m elt curve analysis (data not shown). The primer
matrix identified three possible prim er concentrations that most efficiently amplified the
FIVpco plasm id DNA standard; 300F/300R, 100F/900R, 900F/900R. Because these three
prim er concentrations produced Ct values that were w ithin two cycle numbers o f each
other and taking into account the am ount o f prim er used in each reaction, the primer
concentration o f 300nM forward and 300nM reverse was subsequently chosen as the
optimal FIVpco concentration.

FIVpco Primer O ptim ization
□
■
□
□
■
□

10OF/1 OOR
3 0 0 F /1 0 0 R
9 0 0 F /1 0 0 R
10 0 F /3 0 0 R
3 0 0 F /3 0 0 R
9 0 0 F /3 0 0 R
D 10 0 F /9 0 0 R
□ 300R /900R
■ 9 0 0 F /9 0 0 R

Prim er C o n c e n tr a tio n s

Figure 2.3: O ptim ization o f the FIVpco prim er concentrations. A single FIVpco DNA
plasm id standard (4x10* copies per reaction) was am plified through real-time PCR with
different concentrations o f both forward and reverse FIVpco prim er indicated in the legend.

Investigating the accuracy o f the real-time PCR quantification with the optim ized myosin
prim er and probe concentrations
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Although both prim er sets amplified a single PCR product, the accuracy o f the
real-tim e assay needed to be determined. To this end, the m yosin plasm id DNA standards
were am plified in parallel to a series o f known genomic cougar DNA concentrations to
quantify the num ber o f cell equivalents. Given that an animal cell contains 2 copies of
DNA per cell and that animal genomic DN A w eighs about approximately 1.9*10*^
daltons, a single cell contains six picograms o f DNA (Sambrook, 1989). Therefore, the
theoretical num ber o f cougar cells w ithin each reaction was calculated. The theoretical
number o f cougar cells was then com pared to the number o f cell equivalents quantified
by the m yosin real-time PC R assay (Table 2.2). W e assumed that a single cell contains
two copies o f a gene, therefore, the number o f cell equivalents per reaction was
calculated by dividing the num ber o f m yosin copies quantified by real-time PCR by a
factor o f two. The num ber o f cells was also enumerated prior to DNA purification, which
supported the num ber o f theoretical cougar cells.

Table 2.2: Com parison o f the number o f cell equivalents quantified theoretically and
through the m yosin real-tim e PCR assay.
Concentration of
cougar genomic DNA
(ng/reaction)

Number of cell
equivalents from real
time quantification
(cells/reaction)

Number of cell
equivalents at 6 pg/ul
(cells/reaction)

Fold difference
between real-time
and theoretical
cell quantification

2.855x10^

4.76x10®

2.33 x10^

-2

2.855x10'

4.76x10®

4.26 x1Q4

8.9

2.855x10'

4.76x10'

2 .04 x10^

4.3

2 855x10^

5.0

2.3 x10^

4.6

The results, w hich are summarized in Table 2.2, clearly indicate the numbers of
cell equivalents in the three m ost dilute samples were all overestimated by more than a
factor o f 4. However, the m ost concentrated sample (> 2.0 pg/reaction) did estimate the
20

num ber o f cell equivalents correctly. These results suggested that either the assay was
optim ized and DNA w as lost or degraded in the m ost dilute samples prior to
quantification or that the assay was not optim ized and the m ost concentrated sample did
not am plify efficiently.
Real-time quantification is know n to be accurate between 0.1 and 1.0 pg o f DNA
per reaction (ABI technical bulletin #43044490), w hich suggests that the most
concentrated sample contained an excess am ount o f DNA in the PCR reaction that
inhibited real-time amplification. M oreover, additional experimental data indicated that
w hen enum erating m ore than 10^ cell equivalents per reaction, am plification is not as
efficient com pared to genomic samples with less than 10^ cell equivalents per reaction
(data not shown). Therefore, the m ost concentrated sample did not amplify properly
indicating the quantification o f cell equivalents was incorrect based on the myosin
standard curve and further optim ization was necessary.
Since the quantification o f cell equivalents is based upon the myosin standard
curve, the inaccurate quantification may be due to unequal amplification efficiencies
between the DNA plasm id standards and the genomic unknowns. Therefore, the effect o f
carrier DNA and conformation o f the plasm id DNA standards on real-time amplification
was investigated.

Investigating the effect o f carrier DNA on real-tim e amplification
The effect o f carrier DNA on real-time am plification was previously described in
a real-tim e PCR assay that quantified FIV proviral loads in domestic cats (Leutenegger et
al., 1999). This study determined that the Ct values o f DNA plasm id standards decreased.
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on average 0.5 cycle numbers, w ith the addition o f carrier DNA. M oreover, the optimal
carrier D N A concentration was determined to be 30 ng/reaction. Therefore, we
investigated w hether carrier DN A had an effect on the am plification o f the myosin
plasm id DNA standards.
To this end, a series o f m yosin DNA plasm id standards were serially diluted in
the presence o f either no carrier DNA, carrier DNA at a final concentration o f 3
ng/reaction or carrier DNA at a final concentration o f 30 ng/reaction. The three standard
curves were subsequently am plified simultaneously through real-time PCR (Fig.2.4). The
results indicated that the Ct values o f all m yosin plasm id DNA standards decreased
approximately 5 cycles w ith the addition o f carrier DNA at a final concentration o f 30
ng/reaction. M oreover, the influence o f carrier DNA on Ct values was greater in the DNA
plasm id standards w ith the fewest num ber o f copies, which is to be expected due to
reduced amount o f DNA in these low copy num ber standards. Carrier DNA alone did not
amplify above threshold indicating the prim er set was specific for myosin. The addition
o f carrier DNA to the DNA plasm id standards was therefore included in our assay and
the optimal concentration o f carrier was established to be 30 ng/ul.
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Figure 2.4: Effect o f carrier DNA on real-time PCR amplification. Three separate myosin
standard curves, containing either 0, 3 or 30 nanogram s o f carrier DNA per reaction,
were evaluated sim ultaneously through real-time PCR. Each data point represents the
average value o f duplicate reactions.

Investigating the effect o f linearizing plasm id DNA standards on real-time amplification
Since the addition o f carrier DNA influenced the am plification o f the DNA
plasm id standards and the standards m ust am plify w ith equivalent efficiency in order to
accurately quantify a sample, it follows that the environm ent o f the standards within the
PCR reaction should mimic the environment o f the unknowns. Given that cougar
genomic DNA is linear and the plasm id DNA standards are circular, the amplification
efficiencies o f the circular standards and genom ic unknowns may be different. We
therefore investigated the differences in Ct values between linearized and circular myosin
DNA plasm id standards and the effect on quantifying the num ber o f cell equivalents.
To understand the influence o f DNA conform ation on amplification, plasmid
DNA containing the m yosin insert was linearized through a restriction digest with Xho I
that cleaves the vector at a single site. The linearized DNA was then purified with the
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Q IAquick PC R Purification K it (Qiagen) and serially diluted (see M aterials and Methods,
Chapter 3). Circular and linear m yosin DNA plasm id standards were amplified in parallel
both containing carrier DNA at a final concentration o f 30 ng/ul (Fig. 2.5). In addition,
serial dilutions o f cougar genomic DNA was quantified with both set o f standards.
The results indicated that the threshold cycle values were dramatically lower with
linear DNA plasm id standards com pared to the circular standards, suggesting that the
linear DNA standards am plified more robustly (Fig. 2.5). The num ber o f theoretical cell
equivalents (approxim ated at 6 pg/cell) was m ore appropriately quantified by the linear
DNA plasm id standards, w hich exhibited only a 2-fold difference in the number o f cell
equivalents betw een the theoretical and real-time calculations (Table 2.3). The circular
standards again overestim ated the number o f cell equivalents by a factor o f ten.
Consequently, all DNA plasmid standards were linearized prior to real-time amplification.

y = -3.3685X + 41.09
= 0.9936

o

-3.5507X + 39.544
r 2 = 0.9994
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Circular myosin DNA
standards
Linear myosin
standards

Log Starting Quantity

Figure 2.5: Am plification o f circular and linear DNA plasm id standard curves. Two
separate m yosin standard curves, containing either circular or linear DNA plasm id
standards, were am plified simultaneously through real-time PCR. Each data point
represents the average value o f duplicate reactions.
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Table 2.3: V ariation in quantifying the num ber o f cell equivalents by using circular and
linear DNA plasm id standards during real-time PCR.
Concentration
of
cougar
genomic DNA
(ng/reaction)
2.855x10=
1.43x10=
7.14x10°
3 .57x10’

Theoretical num ber of
cell
equivalents at 6 pg/ul
(cells/reaction)
4.76x10=
2.38x1 o '
1.20x10=
5.95x10’

Number of cell
equivalents
quantified with circular
plasmids (cells/reaction)
1.35x10=
1.98x10=
1.07x10'
3.95x10=

Number of cell
equivalents
quantified with linear
plasmids
(cells/reaction)
2.94x10'
4.19x10'
2.61x10=
1.15x10=

Com parison o f am plification efficiencies between plasm id DNA standards and genomic
unknowns
Finally to accurately quantify the num ber o f DNA copies in an unknown sample,
the am plification efficiency o f the standards and unknowns must be equivalent. To
determine whether the standards and unknowns amplify in the same way, the efficiency
o f the reaction m ust be calculated. The efficiency o f a reaction is defined as

and

identifies the number o f PCR products made during each cycle. To determine if
am plification o f the plasm id standards and genomic DNA was equivalent, the myosin
standard curve was com pared to a 10-fold dilution series o f cougar genomic DNA that
spanned the range o f genomic DNA concentrations used to estimate the number o f cell
equivalents (Fig. 2.6). The efficiencies (defined as

o f the plasmid and genomic

samples were 1.90 and 1.91 respectively, indicating that plasm id and genomic DNA
am plified with equivalent efficiency in our assay.
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Figure 2.6: Efficiency com parison between m yosin plasmid DNA standards and cougar
genomic DNA. A series o f ten fold dilutions o f genomic cougar DNA was amplified in
parallel to the m yosin plasm id DNA standards to determine whether amplification
efficiencies were equal. Efficiency is defined as

Optimization o f the FIVpco plasm a viral load real-time PCR assay
FIVpco exists as a cell free RNA virus in the blood. Therefore, to properly quantify

plasma viral loads in infected cougars, an additional reverse transcriptase (RT) step was
required in the existing FIVpco real-time assay. The RT step necessitated the production
o f RNA standards and confirmation that the RNA standards and unknowns amplified
w ith equivalent efficiencies.
Viral genomic RNA was obtained by isolating viral particles from the supernatant
o f a coculture o f infected cougar PBMC. Viral genomic RNA was subsequently purified
and incubated w ith DNase to degrade any contaminating genomic DNA (see Materials
and M ethods, Chapter 3). Viral genomic RNA was quantified through UV
spectrophotom etry and the number o f genomic RNA copies was determined through the
equation below:
1) (base size o f full length genomic RNA (estimated at 9400b))(340 daltons) =
3.196x10^ daltons, (daltons = grams/mole)
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2) (3.196x10^ grams/mole) / (6.023 x 10^^ molecules/m ole) = 5.31'^*
grams/molecule
3) RN A concentration (g/|il) / 5 . 3 grams/molecule = number o f RNA
m olecules/pl
A fter the num ber o f genom ic RNA copies per m icroliter was determined, RNA standards
were created through a series o f serial dilutions in DEPC-treated water.

Investigating the effect o f carrier RNA on RT real-tim e amplification
The effect o f carrier RNA on the am plification in the RT real-time assay was then
investigated because o f two factors. First, carrier DNA dramatically influenced the real
tim e am plification in the FIVpco proviral assay, indicating that the addition o f carrier
played an im portant role in the real-time PCR assay (see above). Second, viral RNA
purified from the plasm a o f infected cougars is eluted in DEPC-treated water containing
carrier tRNA (Sigma) at a final concentration o f 63 ng/pl to aid in recovery. Therefore,
carrier RNA was added to the RNA standards to equalize the RNA concentrations
between standards and unknowns. To determine whether exogenous RNA had an effect
on amplification, two separate RNA standard curves were am plified in parrallel. One
RNA standard curve included no carrier RNA and the other RNA standard included
carrier RNA at a final concentration o f 63 ng/pl.
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Figure 2.7: Effect o f carrier RNA on RT real-time assay. Two RNA standard curves were
am plified in parallel, one w ith carrier RNA and one lacking carrier RNA.

The results indicated that carrier RNA had a greater effect on the amplification
efficiencies o f the RNA standards than the plasm id DNA standards (Fig. 2.7). The more
dilute RNA standards, w hich did not contain any carrier RNA, did not amplify. These
data suggest that either viral RNA was lost during the dilution steps or that the more
dilute RNA standards were not efficiently reverse transcribed. For these reasons the
addition o f carrier RNA was necessary in the RT real-time PCR assay. Carrier RNA
alone did not amplify above threshold. Therefore, the viral RNA standards and the viral
RNA obtained from the plasma o f infected cougars contained the same carrier tRNA
concentrations in order to equalize the efficiency o f reverse transcription and subsequent
amplification.

Com parison o f am plification efficiencies
Finally to determine whether the RNA standards and plasm a unknowns amplified
w ith equal efficiency, three ten fold dilutions o f plasm a RNA from a single cougar were
am plified in parallel w ith the RNA standards (Fig. 2.8). The results indicated that the
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standards and unknowns amplified w ith com parable efficiency, 2.02 and 1.88
respectively. The estim ated log starting quantities o f all three serial dilutions were similar.
The range was from 4.5 to 4.85 log starting RNA copies per ml. However, the most dilute
plasm a unknowns am plified with decreased efficiency. Therefore, the total amount of
plasm a from each cougar was concentrated through ultracentrifugation prior to
am plification to aid in real-tim e detection.
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Figure 2.8: Efficiency com parison o f RNA standards and plasma unknowns. RNA
standards were amplified in parallel w ith serial ten fold dilutions o f plasma from an
infected cougars, YM131, to determine whether am plification efficiencies were equal.
Efficiency is defined as

The optim ized conditions for the real-time FIVpco proviral and plasm a viral load
assays were subsequently em ployed to quantify viral loads from a large representative
group o f infected cougars.
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Chapter 3
M anuscript entitled Quantification o f Feline Immunodeficiency Virus (FIVpco) in
peripheral blood mononuclear cells, lymph nodes and plasma o f naturally infected
cougars

Introduction
Feline imm unodeficiency virus (FIV) is a lentivirus that infects members o f the
Felidae family worldwide. Although all FIV strains detected in wild and domestic cats
form a m onophyletic cluster in a phylogeny o f lentiviruses, each feline species is infected
w ith a distinct virus and infection results in disparate outcomes (Burkhard & Dean, 2003).
FIV is m aintained as an apathogenic infection in some members o f the cat family such as
lions {Panthera led) and cougars {Puma concolor) (Brown et al., 1994, Carpenter &
O'Brien, 1995, Olm sted et al., 1992). However, FIV infection in domestic cats results in a
disease sim ilar to HIV-1 in humans that begins w ith an acute illness and progresses to
imm unodeficiency and ultim ately death (Bendinelli et al., 1995, Pedersen et al., 1987).
The am ount o f circulating virus is a strong prognostic indicator for disease
progression in FIV and HIV-1 infections (Goto et al., 2002, M ellors et al., 1996). In both
naturally and experimentally infected domestic cats, FIV replicates to high titers and
elevated viral loads are associated with shorter survival time and progression to feline
AIDS (Diehl et al., 1996, Goto et al., 2002). Similarly, high plasm a virus loads are
associated with disease progression in HIV-1 (M ellors et al., 1996).
African prim ates are also host to lentivirus infections (simian immunodeficiency
virus, SIV) and, as is the case with endemic feline lentivirus infections, there is no
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evidence o f disease (Beer et al., 1996, Broussard et al., 2001, Chakrabarti et al., 2000).
However, plasm a virus loads in A frican green monkeys (Cercopithecus aethrops) and
sooty m angabeys (Cercocebus ayts) naturally infected with SIVagm and SIVsm,
respectively, are on the order o f 10^ RNA copies per ml (Broussard et al., 2001,
Chakrabarti, 2004). These data indicate that virus replication can be robust even in
asymptomatic infections and thus high levels o f circulating virus are not always
associated w ith disease.
Currently, no viral load data have been determined for endemic FIV infections in
wild felids. FIVpco infects free-ranging cougars in North and South America with
infection prevalence averaging 30% (Carpenter et al., 1996), but reaching as high as 58%
in some populations in the W estern United States (Biek et al., 2003). This prevalence is
remarkable because cougars are solitary carnivores with infrequent conspecific contacts.
Intrahost viral diversity is less than 1% in infected cougars and the evolutionary rate of
FIVpco has been estim ated at 0.1-0.3% /site/year (Biek et al., 2003). This is an order o f
magnitude lower than the estimated rate o f 3% /site/year reported for SIVagm (MullerTrutwin et al., 1996) or 1% /site/year for HIV-1 (Leitner & Albert, 1999, Poss et al., 2004,
Shankarappa et al., 1999). The faster evolutionary rate o f SIV and HIV-1 could be due to
increased viral replication resulting in a rapid accumulation o f mutations and stronger
selection on the virus population. Therefore, based on the lack o f disease, the low
intrahost viral diversity and low evolutionary rates, we hypothesized that viral loads in
cougars would be lower than in pathogenic FIV and HIV-1 infections or in endemic SIV
infection in primates. W e subsequently developed a real-time PCR assay for FIVpco and
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used the assay to determine the amount o f virus present in a large set o f naturally infected
cougars.

M ethods
Study Population and Cougar Samples
Peripheral blood m ononuclear cells (PBMC), lymph nodes (LN) and plasma
samples used in this study were obtained from free-ranging cougars from four Rocky
M ountain populations previously determined to be infected with FIVpco- Genomic DNA
samples from PBM C were obtained from 39 infected cougars. Genomic DNA samples
from LN were obtained from a group o f 10 hunter-killed animals submitted to the
M ontana Departm ent o f Fish, W ildlife, and Parks. Plasm a samples were also obtained
from 32 infected cougars. Genomic DNA was extracted from samples as previously
described (Biek et al., 2003).

Phylogenetic analysis
A fragment o f proviral env was am plified from serial dilutions o f PBMC or lymph
node DNA from all infected cougars evaluated in this study. PCR products were cloned
and sequenced as previously described (Biek et al., 2003). Alignments were conducted in
Lasergene (version 5.5) from DNASTAR, Inc (M adison, WI) using the CLUSTAL W
algorithm. A m axim um likelihood (ML) tree was created in PAUP* (4.10b; Sinauer
Associates, Inc.) (Swofford, 2002) using a GTR+I+G model as determined in Modeltest
(Posada & Crandall, 1998). PLY 1695 (A Y 307116) was used as an outgroup (Biek et al.,
2003). 100 bootstrap iterations were performed. One env sequence for each cougar has
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been subm itted to Genbank under accession numbers A Y l20787, A Y 120790,
AY120793-94, AY120798-802, A Y l20804-810, AY120812, AY120815, D Q 106994-97,
D Q 106999-00, DQ107003-06, DQ107052-54, DQ 107056-60 and DQ 107062-68.

Sequence analysis o f the real-time FIVpco amplicon
A 690 bp fragment o f proviral FIVpco was amplified by nested PCR from DNA
derived from PBM C o f 14 infected cougars, which included representatives o f each viral
lineage. The oligonucleotides used for the first round were Co7990F (5’ATGCAAG TTATG A G ATG TAG -3’ and Co8958R (5’-TTATTCAACCGTTCGCACTT3 ’). The oligonucleotides used for the second round were Co3LTRF (5’ACG G CCTTA G TGG TG TCTCA G -33 and Co8859R (5’CCATTCCTCCCA G TCTACCC-3’). The conditions for the first round o f PCR were as
follows: 3 m in at 94°C followed by 35 cycles o f 94°C for 30 sec, 48°C for 30 sec, 71 °C
for 70 sec and followed by a 5 m in extension at 71°C. The conditions for the second
round o f PCR were as follows: 3 m in at 94°C followed by 35 cycles o f 94°C for 30 sec,
51°C for 30 sec, 71°C for 45 sec and followed by a 5 min extension at 71 °C. The PCR
products were cloned into the pDrive plasmid (Qiagen, Veiencia, CA) and sequenced.

Plasm a Viral RNA Preparation
Plasm a or serum samples were centrifuged for 1.5 h at 100,000 x g. The viral
pellet was resuspended in 140 pi PBS containing Ca^^ and Mg"^^ and incubated for 1 h
w ith DNase. RNA was purified using the QIAamp viral RNA mini kit (Qiagen) and
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eluted in 30 |il DEPC-treated water. Plasm a volumes greater than 2 ml were eluted in 60
|il. Sam ples were stored at -80°C for cDNA synthesis.

Preparation o f DNA and RNA real-time PCR Standards
A plasm id standard for m yosin was constructed by amplifying a 220 bp fragment
o f cougar genomic DNA w ith primers designed to exon 19 o f the cougar myosin gene.
The prim ers used were MyoF (5’-CAAGAACTGGCCCTGGATGAA-3’) and M yoR (5’CTGCA CTTG G A GCTGG A G GTC-3’). The conditions for the PCR were as follows: 3
m in at 94°C followed by 30 cycles o f 94°C for 30 sec, 52°C for 30 sec, 71 °C for 50 sec
and followed by a 5 m in extension at 71°C. The PCR product was cloned into the pCR4Topo plasm id (Invitrogen, Carlsbad, CA). A 690 bp fragment o f the FIVpco genome near
the 3 ’ end o f env was am plified by PCR from cougar proviral DNA as described above.
All plasm ids were linearized and purified with the QIAquick PCR Purification Kit
(Qiagen). Plasm id concentration was determined by UV spectroscopy. All DNA plasmid
standards were diluted in 10 mM Tris containing salmon sperm DNA (Sigma-Aldrich, St.
Louis, MO) as a carrier at a final concentration o f 6 ng/pl.
Virus from the supernatant o f a coculture o f 3201 cells and PBMC o f a naturally
infected cougar, SRF631, was used for the RNA standards. Viral RNA concentration was
determined by UV spectroscopy to estimate copy number. All RNA standards were
diluted in D EPC-treated water and carrier tRNA (Sigma) at a final concentration o f 63
ng/pl. The viral RNA standards and viral RNA obtained from the plasma o f infected
cougars contained equivalent carrier tRNA concentrations.
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FIVpco Real-tim e PCR Quantification
TaqM an chem istry was used to quantify the number o f cell equivalents in each
proviral reaction. For the m yosin reactions, the primers used were M yoTaqM F (5’TG G CCCTG G A TGA A A CTCTA CT-3’) and M yoTaqM R (5’G CCATCTCCTTCTCGG TCTCT-3’). The probe sequence used for this prim er set was
M yoprobe (5 ’-FAM -CAAGATCAAGCCCCTCCTCAAGAGCG-TAM RA-3’).
SYBR green chemistry was used for quantification o f FIVpco from genomic DNA
and plasm a because sequence divergence among FIVpco lineages precluded designing a
suitable probe. The primers used were ETaqF (5’-TGATCCTGATGCTCCACCAAC-3’)
and ETaqR (5’-TCTCA CTCTGTTCTGCCCATT-3’)- The amplification with this pair o f
oligonucleotides produced a fragment o f 170 bp.
Reactions consisted o f 25 pi o f the 2X Universal M aster M ix (Applied
Bio systems, Foster City, CA) containing 100 mM KCl, 40 mM HCl Tris, 1.6mM dNTP,
50 U nits/pl Taq, 6 mM M gCli and 5 pi o f genomic template, in a 50 pi total reaction
volume. Each myosin reaction contained 300 nM M yoTaqM F, 100 nM M yoTaqM R and
50 nM M yoprobe. Each FIVpco proviral reaction contained 300 nM ETaqF, 300 nM
ETaqR and 1:10000 dilution o f SYBR Green I gel stain (BioW hitaker, Walkersville,
MD).
M yosin am plification was 1 cycle o f 95°C for 10 min followed by a two-step
PCR procedure consisting o f 95°C for 15 sec then 60°C for 1 m in for 45 cycles. FIVpco
am plification was similar except that the annealing temperature was 61 °C for 1 min.
A m plification, data acquisition and analysis were performed using the iCycler real-time
PC R detection system (BioRad, Hercules, CA). All FIVpco reactions were evaluated by
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m elt curve analysis to confirm the size o f the amplicon and lack o f prim er dimer
formation. Genomic DNA from uninfected cougars did not amplify with FIVpco specific
oligonucleotides.
Reverse transcription (RT)-PCR was carried out as a two-step procedure for both
the RNA standards and plasm a samples. The reaction mixture, 30 pi total, contain 1 pi
Superscript'^^ III Reverse Transcriptase (Invitrogen), 4 pi 5X RT buffer, 1 nM ETaqR
and 10 pi purified RNA. The reaction was conducted at 50°C for 50 min. and 85°C for 5
min.
Plasm a viral RNA quantification was determined using 50 pi reactions consisting
o f 25 pi 2X Platinum SYBR Green qPCR SuperM ix (Invitrogen), 300 nM ETaqF and
300 nM ETaqR. FIVpco am plification was 1 cycle o f 50°C for 2 m in followed by 1 cycle
o f 95°C for 2 m in then a two-step PCR procedure consisting o f 95°C for 15 sec then
60°C for 45 sec for 45 cycles.
All standards, negative controls and samples were run in duplicate and the
average value o f the copy num ber was used to quantify both FIVpco and myosin. The
m easurements o f m yosin and FIVpco copy numbers were accepted if the coefficients o f
variation (CV) were <20% for m yosin reactions and <35% for FIVpco reactions. FIVpco
copy num ber for provirus was divided by the number o f cells assayed and reported on the
basis o f 10^ PBM C or LN cells. FIVpco copy num ber for plasm a virus was divided by the
volume o f plasm a assayed and reported as the num ber o f viral RNA copies per milliliter
o f plasma.

Statistical Analysis
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The lower limits o f detection for the proviral and plasma viral load real-time PCR
assays w ere set at 100 DNA copies and 320 RNA copies per reaction to account for
increased variability in cycle number in quantifying low copy numbers (see Results).
Samples that am plified below the lower limit o f detection were confirmed by m elt curve
analysis.
Proviral and plasm a viral loads were determined from PBMC and plasma that
were above the low er limit o f detection. The mean and standard deviation o f both
proviral and plasm a viral loads were calculated. 95% confidence intervals were then set
for both population means through the Student’s t distribution. The lower limit o f both
proviral and plasm a viral loads was calculated. The minimum number o f cell equivalents
and m inim um volum e o f plasma per reaction, w hich would generate viral loads within
the 95% confidence intervals, were determined to be 1.16x10^ cells and 100 pi plasma
per reaction. Samples assayed that exceeded the calculated minimum o f cell equivalents
or plasm a volume, but had viral loads below the lower limit o f real-time detection, were
down w eighted with a factor o f 1/VlO to account for increased variability in threshold
cycle numbers at low copy number. Proviral and plasm a samples assayed below the
calculated minim um o f cell equivalents or plasm a volume and samples that did not reach
threshold were excluded from the statistical analysis.
A w eighted univariate analysis o f covariance (ANCOVA) was used to test if any
significant differences existed among the logio proviral and plasm a viral load means due
to differences in age, gender and lineage. Levene’s test o f equality o f error variance was
used to ensure equal variance existed across the lineages. The proviral model was created
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based on the A N CO V A o f proviral load on age, which resulted in separate slopes and
intercepts for each lineage.

Results

Experim ental conditions o f the FIVpco proviral and plasm a viral load real-time PCR
assays
A fragm ent o f exon 19 o f the cougar myosin gene was used to determine the
num ber o f cell equivalents in samples to be quantified for FIVpco pro virus. Amplification
o f the m yosin standard curve was based on Taqman chemistry and was linear over seven
orders o f magnitude. To determine if am plification o f the plasm id standards and genomic
DNA was equivalent, the m yosin standard curve was compared to a 10-fold dilution
series o f cougar genomic DNA that spanned the range o f genomic DNA concentrations
used to estimate the number o f cell equivalents (data not shown). The efficiencies
(defined as

o f the plasm id and genomic samples were 1.90 and 1.91 respectively,

indicating that plasm id and genomic DNA am plified with equivalent efficiency in our
assay. The num ber o f cell equivalents determined for proviral quantifications was
established by calculating the m ean o f two separate myosin quantifications o f genomic
cougar DNA.
The inter-assay variation for myosin quantification was determined by comparing
the values obtained for standard curves amplified in four separate experiments. Five
standards w ith the lowest copy num ber (9.25x10"* to 9.25x10^ copies per reactions) were
used in calculating the CV to measure the variation in the m ost dilute standards (data not
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shown). The average threshold cycle (Ct) CV was 1.04% and the average absolute CV
was 14.52%. These results demonstrate that the assay used to enumerate cell equivalents
is highly reproducible.
Previous work established that mismatches within the real-time primer sites do
not enable accurate quantification because o f variable efficiencies in am plification (Klein
et al., 1999, Leutenegger et al., 1999). Therefore, since the viral sequence diversity
observed among cougar lentiviurses is greater than the diversity observed in FIV in
domestic cats (Carpenter et al., 1996), we considered it necessary to first establish the
phylogenetic affiliation o f all FIVpco samples prior to quantification and then determine
the effect o f nucleotide mismatches on FIVpco real-time amplification. All samples
clustered w ithin five distinct viral lineages based on a fragment o f env (Fig. 3.1). Viral
lineage associations were consistent with those in a ML tree o f 150 individual cougar
sequences from data sets based on env and p o l (unpublished data). The associations o f
lineage one and two were consistent with previously published results (Biek et al., 2003,
Carpenter et al., 1996). The sequence variation in the FIVpco amplicon prim er sites was
then determined from a representative subset o f infected cougars from each viral lineage
(Fig. 3.2). The viral sequence from lineage four was an exact match to the primers. The
sequences from lineage one and three had the same single mismatch in the reverse primer.
The standard from lineage two had a single mism atch in the forward primer and the
standard from lineage five had single mismatches in both the forward and reverse primer
sites.
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Figure 3.1: Phylogenetic relatedness o f FIVpco based on env. An estimate o f the
phylogenetic relationship o f partial FIVpco env sequences from naturally infected cougars
based on m axim um likelihood. The values next to the tree nodes represent bootstrap
values o f > 70 based on 100 bootstrap iterations. PLV was used as an outgroup. The
population affiliation and sex for each cougar is indicated before the animal identification
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num ber (Y, Yellowstone National Park, MT; SR, Snowy M ountain Range, WY; Gc,
G arnet M ountain Range, MT; Jc, Jackson M ountain Range, WY). Sequences used in
real-tim e proviral quantification as plasm id DNA standards are indicated by *.
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Figure 3.2: Sequence variation o f FIVpco in the forward and reverse primer sites. The
alignment shows the num ber o f nucleotide mismatches within the primer sites from a
representative subset o f naturally infected cougars for each viral lineage. Both primer
sequences are shown in the sense orientation. Dots indicate match with the primer
sequences.

W e prepared separate FIVpco standards from sequences that represented each viral
lineage and investigated the effects o f these mismatches on amplification efficiency.
Lineage standards containing no mismatches, or m ism atches in one or both primers were
evaluated sim ultaneously by real-time PCR. Standards from three lineages produced
overlapping curves (Fig. 3.3a) and were not significantly different based on a F test for
significant differences between lines (P = 0.114). Although the differences between DNA
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plasm id standard curves were not significantly different, the error associated with the low
copy num ber standards increased with the number o f primer mismatches. Therefore, for
proviral DNA quantification, a lineage specific standard was used for samples o f each
lineage.
The average Ct CV (3.62%) and the average absolute CV (38.52%) was
calculated to determine FIVpco inter-assay variation (Fig. 3.3b). The inter-assay variation
o f the FIVpco real-tim e assay was greater than the difference between different FIVpco
lineage standards. The average absolute FIVpco inter-assay variation, obtained with SYBR
green, o f 38.52% is com parable to the variation previously described in real-time assays
using Taqm an probes, w hich has been reported to be greater than 35% (Damond et al.,
2001, Desire et al., 2001). As seen in Figure 3.3b, the coefficient o f variation increased at
the lowest copy numbers, where the final standard, 6.45x10^ copies, had the largest CV
value (68.33%). Subsequently, w e set the lower limit o f detection at 100 DNA copies per
reaction to account for the variability associated with the most dilute standard.
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Figure 3.3: Real-time FIVpco proviral standard curves and inter-assay variation. A) A
com parison o f FIVpco DNA standard curves amplified from plasmid standards
representing three viral lineages. The am plification efficiency and the number o f primer
mismatches are indicated for each standard. Copy number at Ct = 30 denotes the number
o f proviral copies calculated from each plasm id standard curve at threshold cycle 30. B)
The inter-assay variation in the SYBR green proviral quantification assay was determined
for the most dilute standards in order to establish the effect o f low copy number on inter
assay variation. Ct mean = m ean value for threshold cycle number, SD = standard
deviation, % CV = coefficient o f variation expressed as a percentage, Abs mean = mean
value for absolute copy number.

For plasm a viral load quantification, a two-step real-tim e PCR assay was
developed that w as linear over six orders o f magnitude from 3.2x10^ to 3.2x10^ copies
(Fig. 3.4). The lower lim it o f detection for this assay was set at 320 RNA copies per
reaction to account for increased variation in threshold cycle num ber with low copy
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num ber standards. Only one RNA standard was am plified in the real-time reverse
transcription (RT) assay because there were no significant differences between separate
proviral standards in am plification and virus representative o f all five lineages have not
been isolated. Because we did not know a priori if we would detect any circulating virus
in cougar blood, the total am ount o f plasm a was concentrated by ultracentrifugation
before RN A isolation to aid in detection. Standards and samples were reverse transcribed
sim ultaneously to ensure sim ilar RT efficiencies within an assay. The inter-assay
variation for RT real-tim e PCR was 3.92% for the average Ct CV and 38.38% for the
average absolute CV (Fig. 3.4). This is similar to the inter-assay variation for the proviral
quantification suggesting that the RT step had minimal effects on assay reproducibility
and is also com parable to variation reported for other real-time RT assays (Gibellini et al..
2004, Gueye et al., 2004).
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Figure 3.4: Real-time FIVpco RNA standard curve and inter-assay variation. The RNA
standard curve shown is from a representative two-step SYBR green RT-PCR real-time
experiment. The inter-assay variation o f the two-step SYBR green RT real-time assay
was determined for the most dilute standards in order to establish the effect o f low copy
num ber on inter-assay variation. FIVpco genomic RNA was prepared from the supernatant
o f a coculture o f PBMC from SRF631, a cougar infected with a lineage 1 virus, and a
domestic cat cell line.

Proviral Loads in naturally infected cougars
Cougar samples quantified in this study were previously determined to be FIVpco
positive by nested PCR. Therefore, the FIVpco real-time PCR assay was utilized only to
quantify viral loads and was not used as a detection method. Thirty-nine cougar PBMC
samples were quantified and 22 (56%) were within our level o f detection. Ten lymph
node (LN) samples were also quantified and five were within the range o f detection
(50%). Samples that had less than 100 proviral copies, which we established as the lower
limit o f detection, were still valuable in our analysis. For example, FIVpco copy number
was below the lim it o f detection in four PBM C and two LN samples despite the fact that
more than 1x10^ cell equivalents were assayed, indicating that the proviral load was low
in those animals. Therefore, 95% confidence intervals for the number o f cells required for
FIVpco detection was established (see M aterials and Methods). Samples that were
adequately assayed but below detection were down weighted to account for increased
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variability associated w ith threshold cycle number. Eight PBMC samples were down
w eighted in the proviral analysis. Samples for which there were insufficient cell numbers
or plasm a volume for adequate sampling were omitted from the statistical analysis. Nine
PBM C samples were om itted from the proviral analysis.
The m ean proviral load per 10^ PBMC was 1.34x10"^ and ranged from 2.9x10^ to
6 . 7 2 x 1 (Fig. 3.5). The lowest proviral loads were adequately assayed, however, the
num ber o f proviral copies quantified was below our limit o f detection. Therefore, these
samples were down weighted. The mean proviral load per 10^ lymph nodes cells was
1.51x10^ (range 8.06x10^ to 2.51x10^). These data indicate that an average o f 1 in 75
circulating cells is infected with FIVpco and 1 in 66 cells in the lymph nodes are infected.
W e tested the hypothesis that average proviral loads in PBMC were equal among
gender, age and lineage using a weighted ANCOVA. These factors were considered
because one or all m ay have a significant biological effect on the amount o f virus in
infected cougars. Previous experimental FIV infections established that the amount o f
virus in domestic cats differs significantly between different field isolates (Pedersen et al..
2001). Therefore, it was important to understand whether these factors influence viral
loads in natural endemic FIV infections. The variation in proviral load was determined to
be equal across lineages through Levene’s test o f equality o f error variance {P = 0.239).
Proviral loads were significantly different between lineages (P = 0.029) and there was a
significant interaction betw een viral lineage and cougar age, indicating that these
variables considered together had an effect on proviral load (P = 0.014). No correlation
was observed between proviral load and gender (P = 0.440).
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Univariate analysis o f covariance demonstrates whether differences between
m eans are statistically significant but not how means differ. Therefore, to understand the
influence o f age and lineage on proviral loads, the linear regression from the ANCOVA
o f proviral load on age was conducted to model the change in lineage specific proviral
loads versus age, w hich resulted in separate curves for each lineage (R^ = 0.549) (Fig.
3.6). Cougars infected w ith viruses from either lineage one or two have an increase in
PBM C proviral loads with age. In contrast, cougars infected with viruses from either
lineage three, four or five exhibit a decrease in proviral loads with age. The linear
regression o f proviral loads from lineages one and two were statistically different from
those o f lineages three, four and five {P < 0.05). However, the differences observed
between lineages three, four and five were not significant {P > 0.24).

Plasm a Viral Load in naturally infected cougars
Thirty-two plasm a samples were quantified and in 21 (66%) o f these samples
FIVpco was detectable in our real-time assay. The plasm a viral loads ranged from
2.30x10^ to 2.81x10^ RNA copies per ml, w ith a m ean o f 5.69x10^ (Fig. 3.5). O f the 11
plasm a samples that were below our limit o f detection, eight samples were not included
in the statistical analysis because an insufficient volume o f plasma was assayed and three
samples were down w eighted as previously described. The variance in plasm a viral loads
was determ ined to be equal across lineages through Levene’s test {P = 0.086). Moreover,
through a univariate ANCOVA, no significant differences were observed between mean
plasm a viral loads for different genders, ages or lineages {P = 0.958, 0.830 and 0.783
respectively). Additionally, we were able to quantify proviral and plasm a viral loads from
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the same blood sample o f 11 cougars in the study (Fig. 3.7). As is evident from Figure 6,
no correlation was observed between proviral and plasm a viral loads

value = 0.133).

These data dem onstrate that FIVpco infected cells produce variable amounts o f virus in the
blood, w hich is not correlated to the number o f infected PBMC, age, gender or viral
lineage.
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5

Figure 3.5: FIVpco proviral and plasm a viral load for each viral lineage. The average
values for each viral lineage are shown next to the horizontal lines. Closed shapes denote
proviral or plasm a viral loads that were within the detection limits established for this
assay. Open shapes denote down weighted proviral or plasm a viral loads.
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Figure 3.6: A w eighted analysis o f covariance o f cougar PBM C proviral loads versus
cougar age. The colors for each viral lineage correspond to the phylogeny displayed in
Fig. 1. The change in lineage specific proviral loads versus cougar age was based on an
ANCOVA o f cougar PBM C proviral loads w ith viral lineage and gender as factors and
age as a covariate. Lineage specific PBM C proviral loads were averaged across gender
because gender was not a significant influence on PBMC proviral loads. The linear
regressions o f proviral loads from lineages one and two, indicated with A, were
statistically different from those o f lineages three, four and five {P < 0.05). However, the
differences observed between lineages three, four and five, indicated with B, were not
significant {P > 0.24).
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sample o f 11 cougars. All samples had at least one viral load param eter that was within
the detection threshold. Diam onds denote proviral and plasm a viral loads within the
detection threshold. Dow n weighted proviral loads are indicated w ith ‘x ’ and
denotes
dow n w eighted plasm a viral loads.

Discussion
Free-ranging cougars are one o f many feline species that harbor an endemic
lentivirus infection w ithout any apparent signs o f disease (Carpenter & O'Brien, 1995,
O lm sted et al., 1992, Troyer et al., 2004). However, it was not known if the lack of
disease observed in naturally infected cougars was a result o f low level viral replication.
Consequently, FIVpco proviral and plasm a viral loads were quantified from naturally
infected cougars through a recently developed real-time PCR assay. This study represents
the most extensive analysis o f proviral and plasm a viral loads in natural, endemic
lentivirus infections to date.
Proviral loads previously reported in infected PBMC from African green monkeys
and sooty m angabeys are on the order o f 10^ to 10^ proviral copies per 10^ cells,
respectively (Beer et al., 1996, Broussard et al., 2001, Chakrabarti, 2004, Muller &
Barre-Sinoussi, 2003, Rey-Cuille et al., 1998). The average cougar PBMC proviral load
was 1.34x10"* proviral copies per 10^ cells. Therefore, FIVpco proviral loads in infected
PBM C are an order o f magnitude higher than in PBMC from infected primates. The
average LN proviral load, which was determined from a separate group o f infected
cougars, was 1.51x10"* proviral copies per 10^ cells. Although the variation around LN
proviral loads was markedly lower than in PBM C, both cougar PBMC and LN cells had
sim ilar average proviral loads. Equivalent PBM C and LN proviral loads have been
previously reported in a large cohort o f long-term naturally infected AGM (Beer et al.,
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1996). These data stand in contrast to other studies that have reported elevated proviral
loads in lymphoid tissue in naturally infected primates and HIV-1 infected humans
(Broussard et al., 2001, Fauci et al., 1996, Rey-Cuille et al., 1998). Finally, plasma viral
loads in naturally infected cougars ranged from 10^ to 10^ RNA copies per ml and are
com parable to virem ia levels previously reported in SlVsm and SIVagm infections
(Broussard et al., 2001, G oldstein et al., 2000, Holzammer et al., 2001, Rey-Cuille et al.,
1998). These data clearly indicate that the absence o f detectable disease in naturally
infected cougars and prim ates is not a result o f low level viral replication.
In epidemic lentivirus infections, such as HIV-1 or FIV in domestic cats, the
am ount o f circulating virus is an accurate predictor o f disease severity. In humans and
domestic cats, plasm a viral loads greater than 10^ copies per ml are correlated to disease
progression and shorter survival tim e (Diehl et al., 1996, Goto et al., 2002, Mellors et al.,
1996). FIVpco infected cougars m aintain plasm a viral loads that are greater than 10^
copies per m l during infection, but these animals remain asymptomatic. Since elevated
plasm a viral loads in infected cougars are not associated with disease, we determined
w hether FIVpco plasm a viral loads were influenced by factors such as age, gender or viral
lineage. However, no significant differences were observed. The lack o f correlation in
plasm a viral loads to these factors m ay reflect the transient nature o f cell-free virus
com pared to the integrated pro virus. Different rates o f cell-free virus clearance and
production have been reported in patients infected with HIV-1, but the lifespan of
infected cells were not significantly different among patients (Perelson et al., 1996).
Therefore, if the am ount o f virus in the blood varies between infected animals, detecting
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a correlation betw een plasm a viral loads and certain factors in a wild population would be
difficult.
FIVpco plasm a viral loads were also evaluated in comparison to PBMC proviral
loads from 11 infected cougars to determine whether a correlation existed between these
two viral com partments though no correlation was observed. In fact the animal with the
highest plasm a viral load (2.81x10^) maintained a proviral load that was below the lower
lim it o f detection (Fig. 7). These data suggest that FIVpco may not be produced from
circulating PBMC. This is consistent with HIV-1 infections where the prim ary site o f
virus production is lymphoid tissue (Haase, 1999) and greater than 90% o f H IV -1 plasma
virem ia is m aintained by a fraction o f the CD4^ T cell population (Ho, 1997, Hufert et al.,
1997).
The large sequence divergence and widespread distribution o f FIVpco in N orth
A m erica indicate that FIVpco has co-evolved with its cougar host for a long time
(Carpenter et al., 1996). The high cell-associated and cell free viral loads documented in
infected cougars may be an effective mechanism by w hich FIVpco can sustain a high
prevalence rate (30-58%) in a solitary species (Carpenter et al., 1996). Indeed, both FIV
cell-associated and cell free virus are able to cause infection in domestic cats (Burkhard
& Dean, 2003, Burkhard et al., 1997). Furthermore, previous FIVpco studies established
that negative selection, w hich constrains genetic diversity, dominates in FIVpco infections
(Biek et al., 2003). Thus the low intrahost viral diversity reported appears to be the result
o f an absence o f strong positive selection on the virus and not to low levels o f viral
replication.

52

Our results indicate that a large proportion o f the variability in PBM C proviral
loads can be ascribed to viral lineage and cougar age (R^ = 0.549). Although the num ber
o f PBM C samples quantified was m oderate (n = 30), there was a strong correlation
betw een PBM C proviral loads to viral lineage and cougar age {P = 0.014). Because
differences in proviral loads eimong viral lineages were most pronounced in adult cougars
(Fig. 6), changes in horm one levels associated with sexual m aturation or activity may
influence viral replication. Activation o f viral transcription occurs in type B (mouse
mam m ary tum or virus) and type C (murine leukem ia virus) retroviruses in response to
adrenal steroids by binding their respective receptors to hormone response elements
located w ithin the long term inal repeat (LTR) (Cato et al., 1988, M iksicek et al., 1986).
Therefore, the physiological state o f a m aturing infected cougar may influence viral
replication and ultim ately affect the num ber o f infected circulating cells. Such a
replication strategy could optimize viral transm ission during contact events. Interestingly,
animals infected w ith viruses from lineage one and two, w hich displayed an increase in
proviral load w ith age, are from the population w ith the highest prevalence o f FIVpco
infection (Biek et al., 2003), suggesting that this strategy leads to a higher likelihood o f
transmission.
In summary, quantification o f FIVpco proviral and plasm a viral loads has
established that infected cougars maintain substantial viral loads that are comparable or
higher than those reported in endemic primate lentivirus infections. These data further
support the prem ise that high levels o f lentiviral replication do not necessarily correlate
w ith disease. Finally, differences observed in cougar PBM C proviral loads correlated to
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viral lineage and host age suggesting that different life strategies exist w ithin FIVpco
lineages.
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Chapter 4:
Conclusions and Future Prospects

The quantification o f FIVpco proviral and plasm a viral loads provided necessary
inform ation about the am ount o f virus m aintained in an endemic lentivirus infection in
cougars. The study also represented the largest viral load study from a naturally infected
w ild population. Interestingly, significant differences observed am ong cougar PBMC
proviral loads correlated to viral lineage and cougar age. Because differences in proviral
loads am ong viral lineages were m ost pronounced in adult cougars, we hypothesize that
sexual m aturation may influence viral replication (see Chapter 3, Discussion). In animals
sexual m aturation is associated w ith an increase in hormone levels, w hich may
differentially influence FIVpco viral replication and result in distinct PBMC proviral loads
among infecting viral isolates.
Adrenal steroids have been previously shown to both increase and decrease viral
replication in distinct lentivirus infections. For example, adrenal steroids have been
previously shown to induce the transcription o f type B (mouse mammary tumor virus,
M M TV) and type C (murine leukem ia virus, M LV) retroviruses (Cato et al., 1988,
M iksicek et al., 1986). In contrast, glucocorticoid dexamethasone (DXM), a steroid
horm one that binds the glucocorticoid receptor, blocks the activation o f H IV -1 replication
in chronically infected cell lines and infected PBM C (Laurence et al., 1989, Mitra et al.,
1993). Steroid hormones exert their effect on viral transcription by binding their
respective receptors, translocating to the nucleus and binding hormone response elements
located w ithin the long terminal repeat (LTR) o f the proviral DNA.
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In addition to the significant differences observed among PBM C proviral loads,
FIVpco lineages differ genetically within their LTR response elements (data not shown).
Consequently, the possibility exists that separate FIVpco isolates m ay respond
differentially to horm one treatment. Therefore, future experiments may entail in vitro
studies to investigate the effect o f hormones on viral transcription and replication.
For example, cultured cougar cells infected w ith separate viral isolates could be
stimulated w ith a series o f steroid hormones to determine w hether infected cells respond
differentially to horm one treatment. Genetic data from FIVpco LTR sequences have
revealed that both the glucocorticoid receptor (OR) and the pituitary transcription factor 1
(Pit-1) response elem ent are differentially encoded with the LTR between FIVpco viral
lineages. O R is a m em ber o f a family o f steroid receptors that bind glucocorticoid
horm ones (GCs) such as cortisol and DXM. GCs regulate physiological responses by
binding to and m odulating the transcriptional activity o f the GR (Picard et al., 1990).
Alternatively, expression levels o f P it-1 have been shown to increase in response to other
hormones inplicated in sexual maturation such as growth hormone (GH) and prolactin
(PRL) (Gonzalez-Parra et al., 1998). Therefore, these four steroids, cortisol, DXM, GH
and PRL m ay be appropriate horm ones to begin an initial investigation o f their effects on
FIVpco viral replication.
The level o f viral replication in infected cougar PBM C can be measured through a
relative real-tim e PCR assay, w hich is able to m easure changes in target mRNA levels.
Relative real-tim e PCR quantifies mRNA levels o f a target gene, in this case possibly orfand evaluates orf-A expression levels against expression levels o f a gene known to
rem ain constant during the cell cycle, for example glyceraldehyde-3-phosphate
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dehydrogenase (GAPDH). Cougar PBMC, infected w ith different viral isolates could be
treated w ith steroid hormones and the level o f viral replication can be assayed over a
period o f time. A dditionally FIVpco proviral loads can be quantified during steroid
treatm ent to understand whether proviral loads change w ith different hormone treatments.
Since proviral loads from both the black and gray lineages increase over time, one can
hypothesize that PBM C infected with these two viral lineages may increase viral
replication and possibly increase proviral loads over the course o f hormone treatment. If
this is indeed the case then a separate study could investigate the physical interactions o f
binding the horm one receptor to the LTR o f FIVpco.
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